FONTANA, Calif.--(BUSINESS WIRE)--May 8, 2006--GEN ID Lab Services, Inc. (“GEN ID”) (OTC:GDLB - News) today announced that with the assistance of S2 Biosciences, Inc. (“S2"), a privately held company, it will be developing new drug candidates to treat Bird Flu infections in humans.
